Work

Exploiting Greatwall inhibition to target cancer specific changes in the G2/M switch system

Year: 2023
Type: dissertation
Abstract: Greatwall kinase (Gwl) manages the balance between mitotic CDK1 and PP2A:B55 activity and is essential for mitotic entry in Xenopus laevis egg extracts. The role of Greatwall in somatic human cells is less clear. While CRISPR/Cas9 screens across a larger panel of cells suggest that Greatwall is essential, previous studies have found that depletion of this kinase is tolerated in some triple-negative breast cancer cells while others appear to be highly sensitive to loss of Greatwall. Moreover, it is unclear to what extent Greatwall kinase activity or kinase-independent functions determine the sensitivity to Greatwall depletion. To address these questions, we have generated a new small molecule that inhibits Greatwall kinase in at low nano-molar concentrations in vitro and at concentrations between 1-2 µM in cells. Various cell lines show significantly different sensitivity to treatment with the Greatwall inhibitor. Sensitivity and resistance to loss of Greatwall activity correlates well when inhibitor treated and Greatwall depleted cells are compared. Analysis of either Greatwall depletion or inhibition in cells shows a varied response to mitotic phosphorylation with a specific subset of approximately 100 peptides showing a highly significant loss of phosphorylation following Gwl inhibition. This response depends on the presence of Greatwall suggesting on-target activity of our compound. The major phenotypic response to Greatwall inhibition is cytokinesis failure, polyploidization and subsequent cell cycle arrest. This phenotype is highly penetrant in sensitive triple-negative breast cancer cells, but less so in untransformed RPE-1 cells. Moreover, concomitant B55 depletion appears to revert this phenotype caused by the inhibitor in the most sensitive breast cancer cell line BT549. Our work demonstrates the effects of acute Greatwall inhibition in mitosis and paves the way for further pre-clinical evaluation of Gwl inhibitors as putative anti-cancer therapeutics.
Author: Abdulrahman Alatawi
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W6981738196
Cites: 231
Cited by:
Related to: 10